Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest BIS Stories

2014-03-19 16:21:02

DUBLIN, Mar. 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/f98md3/25bis[13dioxo ) has announced the addition of the "2,5-Bis[(1,3-dioxobutyl)amino]benzenesulfonic Acid (CAS 70185-87-4) Market Research Report" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) 2,5-Bis[(1,3-dioxobutyl)amino]benzenesulfonic Acid (CAS 70185-87-4) Market Research Report presents comprehensive data on...

2012-08-24 10:21:52

WASHINGTON, Aug. 24, 2012 /PRNewswire-USNewswire/ -- The Export-Import Bank of the United States (Ex-Im Bank) has authorized a $66.3 million guarantee in favor of UPS Capital Business Credit's loan to Bis Enerji Elektrik Uretim AS (Bis) of Turkey for the export of American power-generation equipment to the Republic of Turkey. (Logo: http://photos.prnewswire.com/prnh/20110414/MM83673LOGO ) Ex-Im Bank's financing will support more than 160 American jobs in Houston, Texas;...

2008-10-23 15:00:16

Teen-age members of the Boys & Girls Clubs of Pasadena interested in pursuing careers in technology fields were given a big head start by BIS Computer Solutions, Inc. Executives of the La Crescenta-based computer software company delivered a multi-faceted series of demonstrations and briefings to introduce the teens to the opportunities and challenges they face in carving out a technology-focused career. Miro Macho, founder and chief executive of BIS Computer Solutions, and...

2008-07-24 09:01:13

Aspect Medical Systems (NASDAQ: ASPM), the global market leader in brain monitoring technology, today announced that the Company's letter to the editor regarding a study and editorial evaluating use of BIS(R) technology to reduce the risk of anesthesia awareness was published in the July 24th issue of the New England Journal of Medicine (NEJM). The NEJM also published letters from Dr. Paul Myles and co-investigators from the Australian B-Aware trial published in The Lancet in 2004, Dr. Lulong...